Episode Details
Back to Episodes
UniQure's Gene Therapy Shows Promise, CDC Warns of Bacterial Surge, FDA Reviews ENHERTU Cancer Combo, New HIV Prevention Injection, and more...
Published 10 months ago
Description
(0:10): UniQure's Gene Therapy AMT-130 Slows Huntington's Disease by 75%, Boosts Stock 190%
(2:00): CDC Warns of 70% Surge in 'Nightmare Bacteria' Infections, Urges Global Action Against Antibiotic Resistance
(4:11): FDA Grants Priority Review to ENHERTU Combo for HER2+ Breast Cancer, Promising New Standard of Care
(6:02): Revolutionary $40 HIV Prevention Injection to Reach 120 Countries by 2027
(7:55): Gore's Climate TRACE Unveils Global Pollution Tracking with Satellite and AI Technology
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Tech Space 2.0
(2:00): CDC Warns of 70% Surge in 'Nightmare Bacteria' Infections, Urges Global Action Against Antibiotic Resistance
(4:11): FDA Grants Priority Review to ENHERTU Combo for HER2+ Breast Cancer, Promising New Standard of Care
(6:02): Revolutionary $40 HIV Prevention Injection to Reach 120 Countries by 2027
(7:55): Gore's Climate TRACE Unveils Global Pollution Tracking with Satellite and AI Technology
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Tech Space 2.0